Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B F Banner

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
The Journal of Urology|December 1, 1991
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladderR R Bahnson, B F Banner, M S Ernstoff, et al.
Digestive Diseases and Sciences|October 30, 2001
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trialH L Bonkovsky, D Stefancyk, K McNeal, et al.
Surgery, Gynecology & Obstetrics|January 1, 1984
Cytoprotective effect of prostaglandin E2 in irradiated rat ileumJ E Tomas-de la Vega, B F Banner, M Hubbard, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1989
Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibodyA L Hoffman, L Makowka, D V Cramer, et al.
Virchows Archiv. A, Pathological Anatomy and Histology|January 1, 1981
Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studiesJ Alroy, D Roganovic, B F Banner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 22, 2001
Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injuryR Ricciardi, B K Schaffer, S A Shah, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trialR J Fontana, J Israel, P LeClair, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
The Journal of Urology|December 1, 1991
Immunohistochemical localization of metallothionein in transitional cell carcinoma of the bladderR R Bahnson, B F Banner, M S Ernstoff, et al.
Digestive Diseases and Sciences|October 30, 2001
Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trialH L Bonkovsky, D Stefancyk, K McNeal, et al.
Surgery, Gynecology & Obstetrics|January 1, 1984
Cytoprotective effect of prostaglandin E2 in irradiated rat ileumJ E Tomas-de la Vega, B F Banner, M Hubbard, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|January 1, 1989
Immunomagnetic T-lymphocyte depletion (ITLD) of rat bone marrow using OX-19 monoclonal antibodyA L Hoffman, L Makowka, D V Cramer, et al.
Virchows Archiv. A, Pathological Anatomy and Histology|January 1, 1981
Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studiesJ Alroy, D Roganovic, B F Banner, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 22, 2001
Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injuryR Ricciardi, B K Schaffer, S A Shah, et al.
Hepatology (Baltimore, Md.)|March 8, 2000
Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trialR J Fontana, J Israel, P LeClair, et al.
Pageof 7